Indonesia is enhancing its domestic food production under president-elect Prabowo Subianto's plan, which includes providing free lunches and milk to school students, focusing on livestock management to meet the nutritional needs of its 280 million population. The Australian-developed product, Tri-Solfen, is gaining traction in Indonesia for treating foot and mouth disease (FMD) and lumpy skin disease, reducing antibiotic use and aiding quick recovery, thus lowering antimicrobial resistance risks. FMD affects millions of livestock globally, costing billions in lost production. Tri-Solfen, a topical anaesthetic, numbs pain, reduces infection, and promotes healing for over 24 hours. An FMD outbreak in Australia could lead to significant economic losses, prompting Indonesia to implement a large-scale vaccination program with international support.